Overview

Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
To compare the clinical efficacy and safety of bendamustine hydrochloride versus chlorambucil for initial treatment of chronic lymphocytic leukemia
Phase:
Phase 2
Details
Lead Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Treatments:
Bendamustine Hydrochloride
Chlorambucil